PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironmentWing Lam, Yung-Chi Cheng|Scientific Reports|2015Cited by 111
YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activityWing Lam, Yung‐Chi Cheng|Frontiers in Pharmacology|2023Cited by 8